Analysis

Shifting demand and margins in focus as Fastenal (FAST) prepares for Q4 report

Fastenal Company (NASDAQ: FAST) is gearing up to publish its fourth-quarter 2025 financial results, after effectively navigating an evolving market environment. The report

Constellation Brands (STZ) gets through another difficult quarter with few gains

Shares of Constellation Brands (NYSE: STZ) stayed red on Friday. The stock has gained 4% in the past three months. The beverage

Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results

Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results

Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where

January 8, 2026

What to look for when United Airlines (UAL) reports its Q4 2025 earnings results

Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for

January 8, 2026

Infographic: How Constellation Brands (STZ) performed in Q3 2026

Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to

January 8, 2026

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top